# RSP Systems A/S

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rsp-systems-a-s

- Industry: Medical Devices & Equipment
- Headquarters: Odense, Denmark
- Website: http://www.rspsystems.com
- Total disclosed funding: $4.5M
- Latest round: Series B (Sep 10, 2018)
- Investors on record: 1

## About

RSP Systems A/S specializes in innovative glucose monitoring solutions, offering a non-invasive device designed for continuous tracking of glucose levels, enhancing health management for users.Founded in 2006 in Odense, Denmark, RSP Systems A/S focuses on developing non-invasive glucose monitoring technologies. The company is recognized for its flagship product, GlucoBeam Smart™, which builds on earlier innovations in glucose monitoring. In September 2018, they secured a EUR 3.85 million Series B funding round led by TRUMPF Venture as part of a larger EUR 10.35 million round, aimed at supporting their growth and market expansion. The firm has completed a total of 6 deals to date.RSP Systems offers the GlucoBeam Smart™, a revolutionary non-invasive wearable device for continuous glucose monitoring. This product addresses the discomfort associated with traditional blood sugar testing methods, making it suitable for individuals with Type 1 and Type 2 diabetes as well as those unaware of their glucose levels. The company is committed to expanding its market reach globally, aiming to provide accessible health monitoring solutions across various regions.RSP Systems generates revenue through direct sales of its GlucoBeam Smart™ device and related software services. The pricing model includes an initial purchase for the device and optional subscription plans for enhanced features, ensuring a consistent revenue stream while maintaining customer engagement. As of 2023, the company's EBITDA stands at EUR -1,444,570.30.RSP Systems plans to leverage the recent funding from the September 2018 Series B round to accelerate the development of new products and enhance their market presence. This includes potential launches of upgraded versions of GlucoBeam Smart™, as well as expansion into key international markets. The company aims to establish partnerships with healthcare providers to improve distribution and accessibility of their products, enhancing the management of glucose levels worldwide.

## Funding rounds

- Series B, Sep 10, 2018, $4.5M — TRUMPF Venture

## Investors

- TRUMPF Venture (https://capitalatlas.ai/funds/trumpf-venture) — Series B